Autonomous Therapeutics, Inc. is a preclinical biotechnology company founded in New York City in 2017 by inventors from Harvard Medical School and the University of California, San Francisco (UCSF).

We are developing the first therapies that evolve along with infectious diseases and cancers—to provide lifelong, ‘resistance-proof’ interventions.

Imagine taking a vaccine drug once and never worrying about the flu again.